Michael D. Huband
Department of Antibacterial Biology
Pfizer Global Research and Development
2800 Plymouth Road
Ann Arbor
USA
Name/email consistency: high
- In vitro and in vivo activities of PD 0305970 and PD 0326448, new bacterial gyrase/topoisomerase inhibitors with potent antibacterial activities versus multidrug-resistant gram-positive and fastidious organism groups. Huband, M.D., Cohen, M.A., Zurack, M., Hanna, D.L., Skerlos, L.A., Sulavik, M.C., Gibson, G.W., Gage, J.W., Ellsworth, E., Stier, M.A., Gracheck, S.J. Antimicrob. Agents Chemother. (2007)